Mispregnol (Misoprostol)

Misoprostol, the active ingredient in Mispregnol, is a prostaglandin analog presented as an oral tablet for oral use. It is employed to protect the gastric lining, to induce uterine contractions for labor, and to facilitate medical termination of pregnancy and to assist in cervical ripening before procedures.

GNH USA supplies Mispregnol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across European and global markets.

Mispregnol (misoprostol) is used in several clinical situations that involve prostaglandin‑mediated effects on the gastrointestinal tract and uterine smooth muscle.

Prevention of NSAID‑induced gastric ulcers: reduces ulcer formation by enhancing gastric mucus and bicarbonate secretion. Induction of labor: promotes uterine contractions to initiate or augment labor in term pregnancies. Medical abortion: induces uterine evacuation in combination with a suitable antiprogestin for early pregnancy termination. Cervical ripening: softens and dilates the cervix to facilitate operative vaginal delivery or surgical procedures.

Misoprostol may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Abdominal pain: cramp‑like discomfort in the stomach area. - Diarrhea: loose stools occurring shortly after dosing. - Nausea: feeling of queasiness or urge to vomit. - Fever or chills: transient rise in body temperature.

Serious or Rare Side Effects: - Uterine rupture: tearing of the uterine wall, potentially life‑threatening. - Severe hemorrhage: excessive bleeding, especially during obstetric use. - Allergic reactions: rash, swelling, or anaphylaxis in susceptible individuals.

Before prescribing Mispregnol, clinicians should evaluate patient‑specific factors and monitor for adverse events. - Assess renal function: dose may need adjustment in severe renal impairment. - Avoid in active peptic ulcer disease unless benefits outweigh risks. - Use caution in patients with cardiovascular disease. - Monitor for uterine hyperstimulation during obstetric use. - Avoid concomitant use with other prostaglandin analogs. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and light.

Misoprostol can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - NSAIDs: may diminish the gastroprotective effect of misoprostol. - Antacids containing magnesium or aluminum: can lower misoprostol absorption. - Oxytocin: additive uterine stimulation may cause hyperstimulation. - Warfarin: potential increase in bleeding risk.

Moderate Interactions (Monitor Closely): - Tetracycline antibiotics: may reduce misoprostol efficacy. - Corticosteroids: combined use may raise the risk of gastrointestinal bleeding. - Antihypertensives: prostaglandin activity may potentiate blood‑pressure lowering effects.